Apr 28, 2014
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.01 to $0.00.
The split itself did not change the total investment value.
Institute of Biomedical Research Corp. (MRES) trades on the Other OTC in the Biotechnology industry.
Institute of Biomedical Research Corp. company overviewThe latest split shown was on April 28, 2014. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on April 28, 2014.
Already premium? Sign in